Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study

Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) due to lack of pharmacodynamic data for pimobendan i...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldach, Maureen S., Ueda, Yu, Ontiveros, Eric S., Fousse, Samantha L., Harris, Samantha P., Stern, Joshua A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369151/
https://www.ncbi.nlm.nih.gov/pubmed/30778391
http://dx.doi.org/10.3389/fvets.2019.00015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369151/
https://www.ncbi.nlm.nih.gov/pubmed/30778391
http://dx.doi.org/10.3389/fvets.2019.00015

Ejemplares similares